Weight loss support for younger women, including PCOS

If weight has crept up in your 20s or 30s, or PCOS makes it harder to shift, you are not imagining it. UK-licensed GLP-1 treatment, prescribed by a registered pharmacist, may help. You pay only if you are approved.

A young woman walking outdoors

Why weight can be harder to shift in your 20s and 30s

Losing weight is not only about willpower. For many younger women, and especially with PCOS, the body works against the usual advice. These are some of the reasons the same effort does not always give the same result.

PCOS and insulin

Polycystic ovary syndrome is common, and many women with PCOS have higher insulin levels. This can make it easier to store fat and harder to lose weight, even with a careful diet.

Appetite and food noise

Constant hunger and thoughts about the next snack, often called food noise, can wear down the best intentions. It is a physical signal, not a character flaw.

Hormones and cycles

Hormonal changes across the month can affect appetite, cravings and energy. For some women this makes steady progress feel like two steps forward and one step back.

Busy, stressful lives

Work, study and broken sleep keep stress hormones high, which can encourage the body to hold on to weight. Life in your 20s and 30s is rarely built around a strict routine.

If the diet that works for your friends does not work for you, it is not because you are trying less hard. For many younger women, and with PCOS, the biology is simply different.

How GLP-1 treatment can help

GLP-1 medicines such as Mounjaro and Wegovy are prescription-only treatments that support weight loss in suitable people. They are not a quick fix, and they are not right for everyone. Like all medicines, they can cause side effects, so they are prescribed and supervised by a clinician who checks the treatment is safe and appropriate for you before you start.

The effect most people describe is the same. The constant background hunger quietens down. The thinking about the next snack, the second helpings and the late-night picking, often called food noise, eases off. When hunger is no longer fighting you all day, sensible eating stops feeling like a battle.

In clinical trials at 72 weeks, Mounjaro produced an average 22.5% reduction in body weight and Wegovy an average of 20.7%. These are averages from trials, not a promise. Individual results vary depending on your starting weight, your dose, your lifestyle and how long you stay on treatment.

The medicine does not do the work on its own. What it does is make the rest possible, which matters most when your biology has stopped cooperating.

Treatments for weight loss injections for women

Suitability is decided by our prescribing pharmacist after a clinical assessment, not by a form. Generally, GLP-1 treatment is considered for adults with a BMI over 30, or over 27 with a weight-related health condition. Mounjaro is the most requested by younger women.

Mounjaro KwikPen, tirzepatide weight loss injection
Most requested

Mounjaro

Tirzepatide

From £159/month
  • Average 22.5% body weight loss at 72 weeks
  • Dual-action GLP-1 and GIP receptor agonist
  • Weekly injection
Wegovy FlexTouch pen, semaglutide weight loss injection
Heart health benefits

Wegovy

Semaglutide

From £130/month
  • Average 20.7% body weight loss at 72 weeks
  • GLP-1 receptor agonist
  • Weekly injection

What the pharmacist checks

Every consultation is reviewed personally by the prescribing pharmacist. There is no automated approval, and you pay only if treatment is approved.

The two routes to eligibility in the UK are a BMI of 30 or above, or a BMI between 27 and 29.9 together with a weight-related health condition. Polycystic ovary syndrome (PCOS) is one of the recognised weight-related conditions the pharmacist will consider, alongside others such as high blood pressure, prediabetes or high cholesterol.

You do not need a formal PCOS diagnosis to be considered, and PCOS on its own is not a shortcut past the BMI thresholds. You declare your health conditions and current medicines during the consultation, and the pharmacist reviews everything together before any prescription is issued. If you are trying for a baby, pregnant or breastfeeding, GLP-1 treatment is not suitable, so tell the pharmacist about this and about any contraception you use.

Be honest on the form. The assessment exists to keep you safe, not to catch you out. If treatment is not right for you, the pharmacist will say so plainly and explain why.

What helps alongside the medicine

The women who do best treat the medicine as one part of the plan. These simple habits protect muscle and steady your progress.

Prioritise protein

Protein at every meal protects muscle and keeps you full for longer. It also helps steady energy through the day.

Keep moving

Not punishing workouts. Daily walks and simple strength work two or three times a week hold on to muscle and protect your metabolism.

Drink more water

Easy to forget, and it helps with both appetite and energy through the day.

Stay supervised

Prescriptions are reviewed every 3 months. Regular check-ins mean your dose and progress are monitored and any side effects are managed early.

PCOS and GLP-1: read the guide

What PCOS has to do with weight, who GLP-1 treatment may suit, and how the consultation works. A plain, cautious guide for younger women weighing up their options.

PCOS weight loss in the UK: your questions

GLP-1 medicines such as Mounjaro and Wegovy can support weight loss in suitable adults. Some women with PCOS find weight harder to lose, which is often linked to how the body handles insulin. GLP-1 treatment is not a treatment for PCOS itself. Suitability is decided by our prescribing pharmacist after a clinical assessment of your health, history and current medicines.
No. Eligibility is based on your BMI and a clinical assessment, not on a PCOS diagnosis. If you have PCOS, tell our prescribing pharmacist during your consultation, along with any other conditions and medicines, so they can review everything together.
Both are prescription-only GLP-1 medicines. Which one is suitable, if either, is decided by the prescribing pharmacist after your assessment. Mounjaro is the most requested by younger women, but the right choice depends on your health and history. Individual results vary.
You must be 18 or over. After that, suitability depends on your BMI and a clinical assessment, not your age. Generally, GLP-1 treatment is considered for adults with a BMI over 30, or over 27 with a weight-related health condition.
GLP-1 medicines are not suitable during pregnancy, when trying to conceive, or when breastfeeding. Tell our prescribing pharmacist if you are trying for a baby or using contraception, so they can advise what is safe and suitable for you.
No. There is no subscription. You pay for each month as you go and can stop at any time. You pay only if the pharmacist approves treatment. Your prescription is reviewed every 3 months to confirm it is working for you and remains appropriate.

Find out if treatment is right for you

Check your eligibility in under three minutes. A qualified prescriber reviews your answers personally. No GP appointment needed, and you pay only if approved.

Stay in the loop

Weight-loss tips, news and offers

Join our newsletter for practical weight-loss tips, product news and member-only offers. No spam, unsubscribe anytime.